Mariner’s Cardio Diagnostics CDIO Stock Holding History

Mariner’s Portfolio CDIO Stock Details CDIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,667	Closed	-$16.5K	–	3512
2025 Q1	$16.5K	Buy	+1,667	New	+$26K	﹤0.01%	3388

Other funds holding CDIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mariner's CDIO Position: Q2 2025 in Review

Mariner sold out of Cardio Diagnostics (CDIO) in Q2 2025, closing a stake of 1,667 shares — an estimated $16.5K sold.

Mariner first reported a position in CDIO in Q1 2025 and held it in 1 quarter. The position peaked at $16.5K in Q1 2025. 16 funds tracked by Wall St. Rank hold CDIO as of Q2 2025.

Mariner reported no remaining Cardio Diagnostics position as of Q2 2025 after selling out during the quarter.
Mariner sold 1,667 Cardio Diagnostics shares in Q2 2025, an estimated $16.5K.
Mariner first reported a position in Cardio Diagnostics in Q1 2025 and held it in 1 quarter.
Mariner's Cardio Diagnostics position peaked at $16.5K in Q1 2025.
16 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q2 2025.

Based on Mariner's 13F filing for Q2 2025, filed 14 Aug 2025.